- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05053113
Utilization of a Peer-Based Approach for the Promotion of Physical Activity in Inactive Women
A Peer-Based Approach to Enhance Physical Activity in Dyads of Inactive Women
Study Overview
Status
Conditions
Detailed Description
PRIMARY OBJECTIVE:
I. Determine whether the dyadic behavioral intervention produces greater engagement of moderate-intensity objective physical activity (PA) compared with the individual behavioral intervention.
SECONDARY OBJECTIVES:
I. Determine the effects of the dyadic behavioral intervention on hypothesized intervention mechanisms (e.g., autonomous motivation, social support, autonomy support, self-efficacy), and the associations of those mechanisms with PA outcomes.
II. Determine the effects of the dyadic behavioral intervention on secondary outcomes (i.e., self-reported moderate-intensity PA, lower body strength, blood pressure, anthropometric measures, mean daily steps, sedentary time) compared with the individual behavioral intervention.
III. Determine whether the dyadic behavioral intervention produces greater engagement of moderate-intensity PA compared with the individual control.
OUTLINE: Participants are randomized to 1 of 2 groups.
GROUP 1 (DYADIC INTERVENTION): Participants receive phone calls over 30-45 minutes each from a health coach weekly during month 1, twice monthly during months 2-4, and monthly during months 5-6 for a total of 12 phone calls that focus on identifying needs, practicing autonomy supportive behaviors, and the development of a mutual support plan. Participants also engage in at least one physical activity per week with their partner and monitor their own and each other's activity using a FitBit. Participants also wear an accelerometer for a minimum of 10 hours a day for 7 days. Participants also receive an electronic newsletter twice monthly during months 1-3 and monthly during months 4-6 that provides educational physical activity-related information and tips for overcoming barriers to physical activity.
GROUP 2 (INDIVIDUAL CONDITION): Participants are assigned to one of 2 groups.
GROUP 2A (INDIVIDUAL INTERVENTION): Participants receive phone calls from a health coach as in Intervention I that focus on providing support for behavioral skills, including monitoring physical activity, goal-setting, and problem-solving to overcome barriers to physical activity. Participants utilize a FitBit to monitor their physical activity and receive electronic newsletters twice monthly during months 1-3 and monthly during months 4-6 that provides educational physical activity-related information and tips for overcoming barriers to physical activity. Participants also wear an accelerometer for a minimum of 10 hours a day for 7 days.
GROUP 2B (HEALTH EDUCATION CONTROL): Participants utilize a FitBit to monitor their physical activity and receive electronic newsletters twice monthly during months 1-3 and monthly during months 4-6 to share basic health education related to physical activity and provide support for engagement. Participants also wear an accelerometer for a minimum of 10 hours a day for 7 days.
At completion of study, patients are followed up at 6 and 12 months.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Larkin Strong
- Phone Number: 713-563-8930
- Email: LLStrong@mdanderson.org
Study Locations
-
-
Texas
-
Houston, Texas, United States, 77030
- Recruiting
- M D Anderson Cancer Center
-
Principal Investigator:
- Larkin Strong
-
Contact:
- Larkin Strong
- Phone Number: 713-563-8930
- Email: LLStrong@mdanderson.org
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Self-identify as female
- Age 18-65 years
- Speak English or Spanish
- Physically able to engage in low-to-moderate PA as assessed by the PA Readiness Questionnaire (PAR-Q), or with medical clearance
- Insufficient self-reported moderate-to-vigorous PA (< 150 minutes/week)
- Able to enroll with one eligible adult female partner
- Valid home address in the greater Houston area
- Have a functioning smartphone and able and willing to send and receive text messages
- Willing to use the Fitbit app and device
- Blood pressure reading < 160/100 mm Hg, or with medical clearance
Exclusion Criteria:
- Pregnancy or considering pregnancy during the study period, self-reported
- Currently participating in a program or research study to promote physical activity or weight loss
- Plans to move outside the greater Houston area during the study period
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Group 1 (phone call, FitBit, newsletter, accelerometer)
Participants receive phone calls over 30-45 minutes each from a health coach weekly during month 1, twice monthly during months 2-4, and monthly during months 5-6 for a total of 12 phone calls that focus on identifying needs, practicing autonomy supportive behaviors, and the development of a mutual support plan.
Participants also engage in at least one physical activity per week with their partner and monitor their own and each other's activity using a FitBit.
Participants also wear an accelerometer for a minimum of 10 hours a day for 7 days.
Participants also receive an electronic newsletter twice monthly during months 1-3 and monthly during months 4-6 that provides educational physical activity-related information and tips for overcoming barriers to physical activity.
|
Ancillary studies
Monitor physical activity with FitBit
Other Names:
Wear accelerometer
Other Names:
Receive educational newsletter
Other Names:
Receive phone call from health coach
|
|
Active Comparator: Group 2A (phone call, FitBit, newsletter, accelerometer)
Participants receive phone calls from a health coach as in Intervention I that focus on providing support for behavioral skills, including monitoring physical activity, goal-setting, and problem-solving to overcome barriers to physical activity.
Participants utilize a FitBit to monitor their physical activity and receive electronic newsletters twice monthly during months 1-3 and monthly during months 4-6 that provides educational physical activity-related information and tips for overcoming barriers to physical activity.
Participants also wear an accelerometer for a minimum of 10 hours a day for 7 days.
|
Ancillary studies
Monitor physical activity with FitBit
Other Names:
Wear accelerometer
Other Names:
Receive educational newsletter
Other Names:
Receive phone call from health coach
|
|
Active Comparator: Group 2B (FitBit, newsletter, accelerometer)
Participants utilize a FitBit to monitor their physical activity and receive electronic newsletters twice monthly during months 1-3 and monthly during months 4-6 to share basic health education related to physical activity and provide support for engagement.
Participants also wear an accelerometer for a minimum of 10 hours a day for 7 days.
|
Ancillary studies
Monitor physical activity with FitBit
Other Names:
Wear accelerometer
Other Names:
Receive educational newsletter
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in objective minutes per week of moderate-intensity physical activity
Time Frame: Through study completion, an average of 1 year
|
Will use a linear mixed model (LMM) analysis, which includes the intervention as a fixed effect predictor and a dyad-specific random intercept to account for the dependent nature of the nested design (in the dyadic intervention group) to assess if the dyadic intervention led to increased moderate-intensity physical activity, relative to the individual intervention.
will also assess changes in physical activity across time (i.e., at 6 and 12 months after baseline) using longitudinal data, where both within-dyad and within-subject (repeated measures across time points) correlations will be accounted for.
Relevant covariates (e.g., age, race/ethnicity, dyad relationship, education, household income and composition, employment status, neighborhood environmental characteristics) will be adjusted for in the analysis.
Potential effect modifiers, e.g., depressive symptoms, perceived stress, neighborhood environmental characteristics, will be explored.
|
Through study completion, an average of 1 year
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Larkin Strong, M.D. Anderson Cancer Center
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Neoplasms
- Investigative Techniques
- Equipment and Supplies
- Health Services
- Health Care Facilities Workforce and Services
- Child Health Services
- Community Health Services
- Preventive Health Services
- Socioeconomic Factors
- Population Characteristics
- Electrical Equipment and Supplies
- Diagnostic Equipment
- Wearable Electronic Devices
- Methods
- Early Intervention, Educational
- Educational Status
- Fitness Trackers
Other Study ID Numbers
- 2020-0809 (Other Identifier: M D Anderson Cancer Center)
- NCI-2020-13914 (Registry Identifier: CTRP (Clinical Trial Reporting Program))
- R01HL155310 (U.S. NIH Grant/Contract)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity-Related Malignant Neoplasm
-
Mayo ClinicCompletedMalignant Solid Neoplasm | Hematopoietic and Lymphoid System Neoplasm | Obesity-Related Malignant NeoplasmUnited States
-
Roswell Park Cancer InstituteCompletedObesity-Related Malignant NeoplasmUnited States
-
M.D. Anderson Cancer CenterRecruitingObesity-Related Malignant NeoplasmUnited States
-
Roswell Park Cancer InstituteUB Clinical and Translational Science InstituteSuspendedObesity-Related Malignant NeoplasmUnited States
-
Ohio State University Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedObesity-Related Malignant NeoplasmUnited States
-
M.D. Anderson Cancer CenterActive, not recruitingObesity-Related Malignant NeoplasmUnited States
-
M.D. Anderson Cancer CenterActive, not recruitingObesity-Related Malignant NeoplasmUnited States
-
Florin IordacheCompletedBacterium-Related Malignant Neoplasm
-
Fred Hutchinson Cancer CenterNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Active, not recruitingObesity-Related Malignant NeoplasmUnited States
-
First Affiliated Hospital, Sun Yat-Sen UniversityJingchu University of TechnologyUnknownHuman Papillomavirus-Related Malignant NeoplasmChina
Clinical Trials on Survey Administration
-
Centre Oscar LambretCentre Hospitalier Universitaire de BesanconTerminated
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)TerminatedHealth Status UnknownUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedSarcoma | Breast Carcinoma | Head and Neck CarcinomaUnited States
-
M.D. Anderson Cancer CenterRecruitingHematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm | COVID-19 InfectionUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingMalignant Vascular NeoplasmUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingMelanoma | COVID-19 InfectionUnited States
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)WithdrawnMelanoma | Breast Carcinoma | Lung Carcinoma | Colorectal Carcinoma | Community Practice | Solid NeoplasmUnited States
-
M.D. Anderson Cancer CenterNational Institutes of Health (NIH)Active, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Malignant Solid NeoplasmUnited States
-
University of Rochester NCORP Research BaseNational Cancer Institute (NCI)WithdrawnCommunity Practice | StaffUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedBladder CarcinomaUnited States